Real-time enrollment status for this clonal hematopoiesis clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 8:39 AM UTC
| NCT Number | NCT06701214 |
| Recruiting Status | Recruiting |
| Condition | Clonal Hematopoiesis |
| Phase | Clinical Trial |
| Target Enrollment | 800 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Vanderbilt-Ingram Cancer Center |
| Last Updated on CT.gov | November 22, 2024 (Nov 22, 2024) |
As of July 13, 2026: Clinical trial NCT06701214 is currently recruiting participants. This clinical trial study for clonal hematopoiesis is actively seeking new participants at 1 location across the United States. The study is sponsored by Vanderbilt-Ingram Cancer Center. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06701214 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06701214 was last updated Nov 22, 2024 (November 22, 2024). HelloStudys verifies this status automatically.